100 related articles for article (PubMed ID: 22162658)
1. Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy.
Bizzarri AR; Santini S; Coppari E; Bucciantini M; Di Agostino S; Yamada T; Beattie CW; Cannistraro S
Int J Nanomedicine; 2011; 6():3011-9. PubMed ID: 22162658
[TBL] [Abstract][Full Text] [Related]
2. A nanotechnological, molecular-modeling, and immunological approach to study the interaction of the anti-tumorigenic peptide p28 with the p53 family of proteins.
Coppari E; Yamada T; Bizzarri AR; Beattie CW; Cannistraro S
Int J Nanomedicine; 2014; 9():1799-813. PubMed ID: 24748790
[TBL] [Abstract][Full Text] [Related]
3. p28, a first in class peptide inhibitor of cop1 binding to p53.
Yamada T; Christov K; Shilkaitis A; Bratescu L; Green A; Santini S; Bizzarri AR; Cannistraro S; Gupta TK; Beattie CW
Br J Cancer; 2013 Jun; 108(12):2495-504. PubMed ID: 23736031
[TBL] [Abstract][Full Text] [Related]
4. Chirality switching within an anionic cell-penetrating peptide inhibits translocation without affecting preferential entry.
Yamada T; Signorelli S; Cannistraro S; Beattie CW; Bizzarri AR
Mol Pharm; 2015 Jan; 12(1):140-9. PubMed ID: 25478723
[TBL] [Abstract][Full Text] [Related]
5. Hybridization Kinetics of miR-155 on Gold Surfaces as Investigated by Surface Plasmon Resonance and Atomic Force Spectroscopy.
Botti V; Lavecchia di Tocco F; Cannistraro S; Bizzarri AR
ACS Omega; 2023 Oct; 8(42):38941-38949. PubMed ID: 37901511
[TBL] [Abstract][Full Text] [Related]
6. Efficient Cytotoxicity of Recombinant Azurin in
Ma Y; Zhu G; Feng L; Jiang S; Xiang Q; Wang J
Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892918
[TBL] [Abstract][Full Text] [Related]
7. Computational Modeling, High-Level Soluble Expression and In Vitro Cytotoxicity Assessment of Recombinant
Aslam S; Rehman HM; Sarwar MZ; Ahmad A; Ahmed N; Amirzada MI; Rehman HM; Yasmin H; Nadeem T; Bashir H
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514012
[TBL] [Abstract][Full Text] [Related]
8. Targeting p53 pathways: mechanisms, structures, and advances in therapy.
Wang H; Guo M; Wei H; Chen Y
Signal Transduct Target Ther; 2023 Mar; 8(1):92. PubMed ID: 36859359
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between cancer and Pseudomonas aeruginosa mediates tumor suppression.
Choi JK; Naffouje SA; Goto M; Wang J; Christov K; Rademacher DJ; Green A; Stecenko AA; Chakrabarty AM; Das Gupta TK; Yamada T
Commun Biol; 2023 Jan; 6(1):16. PubMed ID: 36609683
[TBL] [Abstract][Full Text] [Related]
10. Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer.
Bottens RA; Yamada T
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428639
[TBL] [Abstract][Full Text] [Related]
11. Conformational Heterogeneity and Frustration of the Tumor Suppressor p53 as Tuned by Punctual Mutations.
Bizzarri AR
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293489
[TBL] [Abstract][Full Text] [Related]
12. A Method of Tumor In Vivo Imaging with a New Peptide-Based Fluorescent Probe.
Naffouje S; Goto M; Ryoo I; Green A; Das Gupta TK; Yamada T
Methods Mol Biol; 2022; 2394():857-865. PubMed ID: 35094362
[TBL] [Abstract][Full Text] [Related]
13. p28 Bacterial Peptide, as an Anticancer Agent.
Yaghoubi A; Khazaei M; Avan A; Hasanian SM; Cho WC; Soleimanpour S
Front Oncol; 2020; 10():1303. PubMed ID: 32850408
[TBL] [Abstract][Full Text] [Related]
14. Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines.
Silva M; Monteiro GA; Fialho AM; Bernardes N; da Silva CL
Front Cell Dev Biol; 2020; 8():471. PubMed ID: 32733876
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Actions of Azurin and Its Derived Peptide p28.
Huang F; Shu Q; Qin Z; Tian J; Su Z; Huang Y; Gao M
Protein J; 2020 Apr; 39(2):182-189. PubMed ID: 32180097
[TBL] [Abstract][Full Text] [Related]
16. Investigation of a Direct Interaction between miR4749 and the Tumor Suppressor p53 by Fluorescence, FRET and Molecular Modeling.
Bizzarri AR; Cannistraro S
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32098369
[TBL] [Abstract][Full Text] [Related]
17. Imaging and kinetics of the bimolecular complex formed by the tumor suppressor p53 with ubiquitin ligase COP1 as studied by atomic force microscopy and surface plasmon resonance.
Moscetti I; Bizzarri AR; Cannistraro S
Int J Nanomedicine; 2018; 13():251-259. PubMed ID: 29379285
[TBL] [Abstract][Full Text] [Related]
18. Surface Plasmon Resonance Sensing of Biorecognition Interactions within the Tumor Suppressor p53 Network.
Moscetti I; Cannistraro S; Bizzarri AR
Sensors (Basel); 2017 Nov; 17(11):. PubMed ID: 29156626
[TBL] [Abstract][Full Text] [Related]
19. Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.
Gao M; Zhou J; Su Z; Huang Y
Protein Sci; 2017 Dec; 26(12):2334-2341. PubMed ID: 28960574
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
